CA2992497C - Method for producing galactooligosaccharides from lactose - Google Patents

Method for producing galactooligosaccharides from lactose Download PDF

Info

Publication number
CA2992497C
CA2992497C CA2992497A CA2992497A CA2992497C CA 2992497 C CA2992497 C CA 2992497C CA 2992497 A CA2992497 A CA 2992497A CA 2992497 A CA2992497 A CA 2992497A CA 2992497 C CA2992497 C CA 2992497C
Authority
CA
Canada
Prior art keywords
aqueous solution
initial
lactose
acid
adjusting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2992497A
Other languages
French (fr)
Other versions
CA2992497A1 (en
Inventor
Stephen TOMIUK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitalus Nutrition Inc
Original Assignee
Vitalus Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitalus Nutrition Inc filed Critical Vitalus Nutrition Inc
Publication of CA2992497A1 publication Critical patent/CA2992497A1/en
Application granted granted Critical
Publication of CA2992497C publication Critical patent/CA2992497C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036Galactans; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2445Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108Lactase (3.2.1.108)

Abstract

Methods are disclosed for the enzymatic preparation of galactooligosaccharide (GOS) from lactose using two different microbial lactase enzymes to maximize the extent of transgalactosylation during the digestion of lactose. Methods are also disclosed for avoiding the turbidity of a solution comprising GOS and lactose as it is adjusted for incubation with a yeast neutral lactase.

Description

METHOD FOR PRODUCING GALACTOOLIGOSACCHARIDES FROM
LACTOSE
BACKGROUND
1. Field This disclosure relates to the enzymatic preparation of galactooligosaccharide (GOS) from lactose. More particularly, this disclosure relates to the sequential use of two different microbial lactase enzymes to maximize the degree of transgalactosylation during the digestion of lactose.
2. Description of Related Art Galactooligosaccharides (GOS) are non-digestible carbohydrates that serve as the building block of oligosaccharides in human milk. GOS modulate the growth and activity of gastrointestinal microorganisms, and are therefore believed to promote a healthy balance of microorganisms in the gut. Among other things, GOS are believed to reduce levels of blood serum cholesterol, improve mineral absorption, and prevent colon cancer development. The properties of GOS depend significantly on the chemical composition, structure, and degree of polymerization (DP).
GOS can be formed by the digestion of lactose with 13-D-galactoside galactohydrolases. p-D-galactoside galactohydrolases catalyze the hydrolysis of the galactosyl moiety from the non-reducing end of lactose. In addition, p-D-galactoside galactohydrolases can catalyze transgalactosylation in which a galactosyl moiety is transferred to a nucleophilic acceptor other than water, i.e. potentially any sugar present in a reaction medium. Transgalactosylation is a kinetically controlled reaction, and represents competition between the reactions of hydrolysis and synthesis. The ability to favor synthesis over hydrolysis depends on several factors, including the origin of the 13-D-galactoside galactohydrolase and the initial composition of acceptor sugars in the medium (e.g. lactose and galactose) with which the enzymes are presented. If lactose is the initial substrate, transgalactosylation results in the production of GOS comprising a mixture of di- (DP2), tri- (DP3), and even higher oligosaccharides (DP4+) with or without a terminal glucose. The chemical structure and composition of a GOS (e.g. the number of hexose moieties and the types of linkages) affects its properties, such as the fermentation pattern by probiotic bacteria in the gut. The chemical compositions, structure, degree of polymerization, and yield of GOS also depends on the origin of the p-D-galactoside galactohydrolases utilized.
Many adults are lactose intolerant, and thus it is desirable to hydrolyze as much lactose as possible during the preparation of GOS from lactose.
However, reaction conditions that favor the enzymatic digestion of lactose to, for example, less than 20% of the initial lactose concentration tend to also favor the digestion of GOS that is synthesized. Accordingly, reducing lactose concentration may result in reduced yield of GOS.
SUMMARY
This disclosure relates to a method of producing galactooligosaccharide (GOS) from lactose. The method includes incubating an initial aqueous solution comprising lactose at an initial concentration with an acid fungal lactase to produce an intermediate aqueous solution comprising lactose and GOS in which the concentration of lactose is about 30% to about 70% of the initial concentration of the initial aqueous solution; adding a yeast lactase to the intermediate aqueous solution; and incubating the intermediate aqueous solution comprising the yeast lactase to produce a final aqueous solution in which the concentration of lactose is between 0% and 20% of the initial concentration of the initial aqueous solution. Incubating the initial aqueous solution to produce the intermediate aqueous may involve incubating the initial aqueous solution to produce the intermediate aqueous having about 40% of the initial concentration of lactose the initial aqueous solution.
Incubating the initial aqueous solution to produce the intermediate aqueous may involve incubating the initial aqueous solution to produce the intermediate aqueous comprising 49% to 52% DP2 sugar (w/w) of total sugar in the intermediate aqueous solution. Incubating the intermediate aqueous solution with the yeast lactase to produce the final aqueous solution, may
-3-involve incubating the intermediate aqueous solution to produce the final aqueous solution comprising 23.5 % to 25% DP2 sugar (w/w) of total sugar in the final aqueous solution.
The method may further include adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 with KOH, MgCl2, and citric acid prior to adding the yeast lactase. Adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 with KOH, MgCl2, and citric acid may include adjusting the pH to between 6.0 and 7.5. Adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 with KOH, MgCl2, and citric acid may include adjusting the pH to about 6.8. Adjusting the pH of the intermediate aqueous solution with KOH, MgCl2, and citric acid may include sequentially adding KOH, MgCl2, and citric acid to the intermediate aqueous solution.
Sequentially adding KOH, MgCl2, and citric acid to the intermediate aqueous solution comprises, in sequential order: adjusting the pH of the intermediate aqueous solution to about 9.2 with KOH; adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution; and adjusting the pH of the intermediate aqueous solution from about 9.1 to about 6.8.
The acid fungal lactase may be a fungal 8-D-galactoside galactohydrolase.
The fungal 13-D-galactoside galactohydrolase may be derived from an Aspergillus species. The Aspergillus species may be Aspergillus oryzae. The concentration of the acid fungal lactase may be expressed in terms of lactase units (LU) per gram of lactose in the solution. The concentration of the acid fungal lactase in the initial aqueous solution may be between 1 and 300 LU
per gram of lactose in the initial aqueous solution. The concentration of the acid fungal lactase may be between about 10 and about 20 LU per gram of lactose in the initial aqueous solution. The concentration of the acid fungal lactase may be between about 15 and about 17 LU per gram of lactose in the initial aqueous solution. The concentration of the acid fungal lactase may be about 16.7 LU per gram of lactose in the initial aqueous solution.
Alternatively, the concentration of the acid fungal lactase may be about 5.6 LU
-4-per gram of lactose in the initial aqueous solution, or about 5.8 LU per gram of lactose in the initial aqueous solution.
The yeast neutral lactase may be a yeast p-D-galactoside galactohydrolase.
The yeast 13-D-galactoside galactohydrolase may be derived from a Kluyveromyces species. The Kluyveromyces species may be Kluyveromyces lactis.
Adding the yeast neutral lactase to the intermediate aqueous solution may include adding the yeast lactase to a concentration of between 1 and 50 LU
per gram of lactose in the intermediate aqueous solution. Adding the yeast neutral lactase to the intermediate aqueous solution may include adding the yeast lactase to a concentration of about 4 to about 5 LU per gram of lactose in the intermediate aqueous solution. Adding the yeast neutral lactase to the intermediate aqueous solution may include adding the yeast lactase to a concentration of about 4.7 LU per gram of lactose in the intermediate aqueous solution. Adding the yeast neutral lactase to the intermediate aqueous solution may include adding the yeast lactase to a concentration of about 4.4 LU per gram of lactose in the intermediate aqueous solution.
The initial concentration of lactose in the initial aqueous solution may be between 15 and 63 Bx. The initial concentration of lactose in the initial aqueous solution may be between about 30 Bx and about 60 Bx. The initial concentration of lactose in the initial aqueous solution may be about 45 Bx.
The initial concentration of lactose in the initial aqueous solution may be about 53 Bx.
The initial aqueous solution may be incubated with the fungal acid lactase at a temperature between about 25 and 65 C. The temperature may be between about 40 and about 55 C. The initial aqueous solution may be incubated with the fungal lactase at a temperature of about 53.5 C.
-5-The initial aqueous solution may be incubated with the fungal lactase at a pH
between about 2.5 and about 8Ø The initial aqueous solution may be incubated with the fungal lactase at a pH between about 3.5 and about 6.5. In particular embodiments, the initial aqueous solution is incubated with the fungal lactase at a pH between about 4.5 and about 5.5.
In some embodiments, the method includes deactivating the fungal acid lactase prior to adding the yeast neutral lactase. In some embodiments, deactivating the fungal lactase comprises adjusting the pH of the intermediate aqueous solution to about 2 or less. In some embodiments, deactivating the fungal acid lactase includes adjusting the pH of the intermediate aqueous solution to about 2. The pH of the intermediate aqueous solution may be adjusted with hydrochloric acid (HCI) to deactivate the fungal lactase. In some embodiments, deactivating the fungal acid lactase includes heating to above 72 C.
The intermediate aqueous solution may incubated with the yeast neutral lactase at a temperature between about 4 and about 50 C. In some embodiments, the intermediate aqueous solution is incubated with the yeast lactase at a temperature between about 30 and about 45 C. In some embodiments, the intermediate aqueous solution is incubated with the yeast lactase at a temperature of about 36.5 C.
The method may further include deactivating the yeast lactase. In some embodiments, deactivating the yeast lactase includes adjusting the pH of the final aqueous solution to about pH 5.5. In some embodiments, the pH of the final aqueous solution is adjusted to about pH 5.5 with citric acid. In some embodiments, deactivating the yeast lactase includes incubating the final aqueous solution at 72 C.
The method may further include partially removing glucose and galactose from the final aqueous solution by chromatography to produce a GOS-enriched solution.
-6-The method may further include removing the fungal acid lactase, the yeast neutral lactase, glucose and galactose from the final aqueous solution by chromatography.
In some embodiments, the fungal acid lactase and the yeast neutral lactase, is removed from the final aqueous solution by ion exchange chromatography.
In some embodiments, the glucose and/or galactose is at least partially removed from the final aqueous solution by ion exchange, filtration, chromatographic separation, or additional fermentation reactions. In some embodiments, chromatographic separation comprises simulated moving bed chromatography.
This disclosure further relates to a galactooligosaccharide (GOS) syrup produced according to a method as described above. In some embodiments, the GOS syrup is at least 40% GOS w/w of the total carbohydrate in the GOS
syrup. In some embodiments, the GOS syrup is at least 65% GOS w/w of the total carbohydrate in the GOS syrup.
In some embodiments, the wherein ratio of DP2:DP3:DP4 in the GOS syrup is about 2:3:1.
This disclosure also relates generally to the use of a p-D-galactoside galactohydrolase derived from Aspergillus oryzae in combination with a p-D-galactoside galactohydrolase derived from Kluyveromyces lactis in the preparation of galactooligosaccharide (GOS) syrup from an aqueous solution comprising lactose, wherein the GOS syrup is at least about 40% GOS w/w of the total carbohydrate in the GOS syrup. The p-D-galactoside galactohydrolase derived from Aspergillus oryzae is for incubation with the aqueous solution prior to incubation of the aqueous solution with the p-D-galactoside galactohydrolase derived from Kluyveromyces lactis.
- 7 -In some embodiments, the GOS syrup may be at least about 60% GOS w/w of the total carbohydrate in the GOS syrup. In some embodiments, the GOS syrup may be about 65%
GOS w/w of the total carbohydrate in the GOS syrup.
This disclosure also relates generally to the use of a f3-D-galactoside galactohydrolase derived from Kluyveromyces lactis for increasing the amount of galactooligosaccharide (GOS) in an aqueous solution comprising lactose that has been previously treated with a p-D-galactoside galactohydrolase derived from Aspergillus oryzae. In some embodiments, the amount of GOS
may be increased to at least 40% w/w of total carbohydrates in the solution.
In some embodiments, the diversity of GOS may be increased.
This disclosure also relates generally to the use of a p-D-galactoside galactohydrolase derived from Aspergillus oryzae in combination with a p-D-galactoside galactohydrolase derived from Kluyveromyces lactis in reducing the concentration of lactose in an aqueous solution to less than 20% w/w of the initial concentration of lactose. The P-D-galactoside galactohydrolase derived from Aspergillus oryzae is for incubation with the aqueous solution prior to incubation of the aqueous solution with the p-D-galactoside galactohydrolase derived from Kluyveromyces lactis.
Various embodiments of the claimed invention relate to a method of producing galactooligosaccharide (GOS) from lactose, the method comprising: incubating an initial aqueous solution comprising lactose at an initial concentration with an acid lactase, wherein the acid lactase is an acid P-D-galactoside galactohydrolase derived from Aspergillus otyzae, to produce an intermediate aqueous solution comprising lactose and GOS in which the concentration of lactose is about 30% to about 70% of the initial concentration of the initial aqueous solution, and in which DP2 sugar is about 49% to about 52% by weight of total sugar in the intermediate aqueous solution; adjusting the intermediate aqueous solution, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0; adding a neutral lactase to the intermediate aqueous solution, wherein the neutral lactase is a neutral p-D-galactoside galactohydrolase derived from a Kluyveromyces lactis; and incubating the intermediate aqueous solution comprising the - 7a -neutral lactase to produce a final aqueous solution in which the concentration of lactose is about 20% or less of the initial concentration of the initial aqueous solution. Various embodiments of the claimed invention relate to use of an acid lactase in combination with a neutral lactase in the preparation of galactooligosaccharide (GOS) syrup from an aqueous mixture comprising lactose, wherein the GOS syrup comprises at least about 40%
GOS w/w of the total carbohydrate in the GOS syrup, and wherein the GOS syrup comprises about 23.5%
to about 25% DP2 sugar by weight of total sugar in the aqueous solution.
Various embodiments of the claimed invention relate to a method of minimizing the turbidity of a reaction mixture comprising a solution comprising lactose and galactoligosaccharides as it is adjusted from a pH of about 4.5 to 5.5 for incubation with a neutral lactase at a pH of about 6.0 to about 7.5, the method comprising, in sequential order: adjusting the pH of the solution to about 9.2 with KOH; adding about 0.16 g of MgCl2 per 100 g of the solution to the intermediate aqueous solution; and adjusting the pH of the solution with an acid to between about 6.0 and about 7.5.
Various embodiments of the claimed invention relate to a method of minimizing the turbidity of a reaction mixture comprising a solution comprising lactose and galactoligosaccharides as it is adjusted from basic pH toward a neutral pH for incubation with a neutral lactase, the method comprising adjusting a salt concentration of the solution with MgCl2 before adding an acid to reduce the pH toward the neutral pH.
Various embodiments of the claimed invention relate to a method of producing galactooligosaccharide (GOS) from lactose, the method comprising: incubating an initial aqueous solution comprising lactose at an initial concentration with an acid 13-D-galactoside galactohydrolase derived from Aspergillus oryzae to produce an intermediate aqueous solution comprising lactose and GOS in which the concentration of lactose is about 30%
to about 70%
of the initial concentration of the initial aqueous solution; adjusting the intermediate aqueous solution, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0; adding neutral p-D-galactoside galactohydrolase derived from Kiuyveromyces lactis to the intermediate aqueous solution; and incubating the intermediate aqueous solution comprising the neutral 13-D-galactoside - 7b -galactohydrolase until DP2 sugar is about 23.5% to 25% of total sugar by weight to produce a final aqueous solution in which the concentration of lactose is about 20% or less of the initial concentration of the initial aqueous solution.
Various embodiments of the claimed invention relate to use of an acid P-D-galactoside galactohydrolase derived from Aspergillus otyzae in combination with a neutral galactoside galactohydrolase derived from Kluyveromyces lactis in the preparation of galactooligosaccharide (GOS) syrup from an aqueous mixture comprising lactose, wherein the GOS syrup comprises at least about 40% GOS w/w of the total carbohydrate in the GOS
syrup.
Other aspects and features of the present invention will become apparent to those ordinarily skilled in the art upon review of the following description of specific embodiments of the invention in conjunction with the accompanying figures.
BRIEF DESCRIPTION OF THE DRAWINGS
In drawings which illustrate embodiments of the invention, Figure 1 is a flow diagram of a method of producing GOS syrup as disclosed herein in Example 5.
8 Figure 2 is a HPLC chromatogram following primary transgalactosylation of lactose using fungal p-D-galactoside galactohydrolases from Aspergillus oryzae as disclosed herein in Example 5.
Figure 3 is a HPLC chromatogram following secondary transgalactosylation of lactose using yeast p-D-galactoside galactohydrolases from Kluyveromyces as disclosed herein in Example 5.
Figure 4 is a flow diagram of a method of producing GOS syrup as disclosed herein in Example 6.
Figure 5 is a HPLC chromatogram following primary transgalactosylation of lactose using fungal p-D-galactoside galactohydrolases from Aspergillus oiyzae as disclosed herein in Example 6.
Figure 6 is a HPLC chromatogram following secondary transgalactosylation of lactose using yeast p-D-galactoside galactohydrolases from Kluyveromyces as disclosed herein in Example 6.
Figure 7 is a HPLC chromatogram of final product after purification and enrichment as disclosed herein in Example 6.
DETAILED DESCRIPTION
Definitions "DP" as used herein refers to the degree of polymerization of the GOS. A
disaccharide GOS is characterized as a "DP2". A trisaccharide GOS is characterized as a "DP3". A tetrasaccharide GOS is characterized as a "DP4".
The skilled person will understand that each grouping may include a plurality
-9-of species of GOS which differ in terms of the sequence of sugar moieties and the linkages between moieties.
"Initial aqueous solution" as used herein refers to the lactose solution that is prepared for and is digested by the acid fungal lactase as the primarily active lactase.
"Initial concentration of lactose" as used herein refers to the amount of lactose that is added to create the initial aqueous solution, including any lactose that may be added to the initial aqueous solution after incubation with the acid fungal lactase has commenced.
"Intermediate aqueous solution" as used herein refers to the resulting lactose solution upon the effective termination of the digestion of the initial aqueous solution by the acid fungal lactase that is then digested by the yeast neutral lactase.
"Final aqueous solution" as used herein refers to the resulting lactose solution upon the effective termination of the digestion of the intermediate aqueous solution by the yeast neutral lactase.
This disclosure relates to methods of producing galactooligosaccharide (GOS) from lactose using a combination of acidic lactases and neutral lactases. More particularly, the method comprises incubating an aqueous solution comprising lactose with an acid fungal lactase. The acidic fungal lactase hydrolyses the lactose in the solution to galactose and glucose. The lactase further catalyzes transgalactosylation reactions in which the galactosyl moiety is transferred to potentially any sugar moiety present in the solution (e.g. galactose, glucose, lactose, etc.) to produce GOS comprising a mixture of DP2, DP3, DP4, DP5, and even higher order oligosaccharides.
-10-Primary Digestion with an Acid Fungal Lactase In various embodiments of the methods disclosed herein, the acid fungal lactase is a fungal p-c-galactoside galactohydrolase. The p-c-galactoside galactohydrolase may be derived an Aspergillus species. In particular embodiments, the p-c-galactoside galactohydrolase is derived from Aspergillus oryzae, such as the p-c-galactoside galactohydrolase available from Enzyme Development Corporation (New York) as ENZECOTM Fungal Lactase Concentrate. The skilled person will understand that the determination of lactase units (LU) will be specified on the TDS for an enzyme. One LU may be defined as that quantity of enzyme which will liberate 1.0 pmol/min of o-nitrophenol under the conditions of the assay specified in the TDS. The concentration of the acid fungal lactase in the initial aqueous solution may be between 1 and 300 LU per gram of lactose in the initial aqueous solution. The concentration of the acid fungal lactase may be between about 10 and about 20 LU per gram of lactose in the initial aqueous solution. The concentration of the acid fungal lactase may be between about 15 and about 17 LU per gram of lactose in the initial aqueous solution. In particular embodiments, the concentration of the acid fungal lactase may be about 16.7 LU per gram of lactose in the initial aqueous solution. In particular embodiments, the concentration of the acid fungal lactase may be about 5.6 LU per gram of lactose in the initial aqueous solution. In particular embodiments, the concentration of the acid fungal lactase may be about 5.8 LU per gram of lactose in the initial aqueous solution. Nevertheless, the skilled person will understand that the methods disclosed herein may be performed with a wide range of acid lactase concentrations depending on a number of factors including the initial concentration of lactose in the aqueous solution, the length of time for which the reaction is allowed to proceed, the pH, and the reaction temperature.
The source of lactose may vary. The lactose can be provided in the form of milk permeate. Alternatively, the lactose can be provided as edible crystalline lactose commonly available from commercial suppliers. The initial
-11-concentration of lactose in the initial aqueous solution should be in the range of 15 to 63 Bx. Nevertheless, the skilled person will understand that, for commercial purposes, the initial concentration of lactose should be higher than 15 Bx, as lower concentration of lactose favors hydrolysis over the transgalactosylation, thereby leading to lower GOS yields. Moreover, lower initial concentrations of lactose necessitate larger volumes to be processed in order to obtain the same amount of products, and thus more resources for downstream separation such as chromatographic apparatuses and evaporators. Accordingly, the initial concentration of lactose and in an initial aqueous solution will preferably be between about 30 Bx and about 60 Bx. In particular embodiments, the initial concentration of lactose and in the initial aqueous solution is about 45 Bx. In particular embodiments, the initial concentration of lactose and in the initial aqueous solution is about 53 Bx.
The pH of the initial aqueous solution should be in the range of about 2.5 to about 8Ø The skilled person will understand, however, that the pH of the initial aqueous solution should be close to the optimal pH for the enzyme.
Accordingly, in some embodiments, the pH of the initial aqueous solution will be between about 3.5 and about 6.5. In some embodiments, the pH of the initial aqueous solution will be between about 4.5 and about 5.5. For example, ENZECOTM Fungal Lactase Concentrate has activity within a pH range of about 2.5 to about 2.8, although the activity may be slow outside a pH range of about 3.5 to about 6.5. The ENZECOTM Fungal Lactase Concentrate, for example, has a pH optimum of between 4.5 and 5Ø
The skilled person will understand that the pH of a solution comprising lactose may vary depending on the concentration of lactose and the source of lactose. Accordingly, it may be necessary to adjust the pH of the initial aqueous solution within the suitable pH range to bring the pH of the initial aqueous solution within the desired range.
The initial aqueous solution is incubated with the fungal lactase at a temperature between about 35 and about 65 C. ENZECOTM Fungal Lactase
-12-Concentrate, for example, has a temperature optimum of 55 C at pH 4.5 and 6.5. Thus, in some embodiments, the initial aqueous solution is incubated with the acid fungal lactase at a temperature between about 50 and about 56.5 C.
In some embodiments, the initial aqueous solution is incubated with the acid fungal lactase at a temperature between about 50 and about 55 C. In particular embodiments, the initial aqueous solution is incubated with the acid fungal lactase at a temperature of about 53.5 C.
The skilled person will understand that the methods disclosed herein are not limited by any specific reaction time for the incubation of the initial aqueous solution with the acid fungal lactase. Rather, the reaction is allowed to proceed until about 20% to about 70% of the lactose provided in the initial aqueous solution is hydrolyzed (i.e. until the concentration of lactose is between about 20% to about 70% of the initial concentration of lactose in the initial aqueous solution). In particular embodiments, the reaction is allowed to proceed until about 40% of the lactose provided in the initial aqueous solution is hydrolyzed (i.e. until the concentration of lactose is about 40% of the initial concentration of lactose in the initial aqueous solution) and/or until DP2 sugars comprise 49% to 52% (w/w) of total sugar in the intermediate aqueous solution. Accordingly, the concentration of lactose and other sugars in the initial aqueous solution may be monitored from time to time in order to identify an appropriate time to end the incubation with the acid fungal lactase. The skilled person will understand that incubation time depends on a combination of temperature, initial lactose concentration, pH, and lactase concentration.
Reactions may be run quickly with a large concentration of enzyme if enzyme cost in not important. Alternatively, enzyme costs may be saved if a reaction is carried out more slowly. Parameters may also be adjusted depending on how the reaction time is to be logistically tied in downstream processes.
Secondary Digestion with a Neutral Yeast Lactase Once the desired concentration of lactose in the aqueous solution (and/or a DP2 sugar concentration of about 49% to 52% (w/w) of total sugar in the
-13-intermediate aqueous solution) is achieved, this intermediate aqueous solution is incubated with a yeast neutral lactase. Prior to adding the yeast neutral lactase, it may be preferable to deactivate the acid fungal lactase.
Deactivating the acid fungal lactase may involve adjusting the pH of the intermediate aqueous solution to about 2 or less with, for example, HCI.
Deactivating the acid fungal lactase seeks to minimize hydrolysis of GOS by the acid fungal lactase, and thereby maximize GOS yield. However, the skilled person will understand that active steps to deactivate of the acid fungal lactase may not be completely necessary.
The neutral yeast lactase is added to the intermediate aqueous solution comprising GOS and about 20 to about 70% of the initial lactose to a concentration. In various embodiments of the methods disclosed herein, the neutral yeast lactase is a yeast p-D-galactoside galactohydrolase. The pi-D-galactoside galactohydrolase may be derived from a Kluyveromyces species.
In particular embodiments, the p-D-galactoside galactohydrolase is derived from Kluyveromyces lactis, such as the p-D-galactoside galactohydrolase available from Enzyme Development Corporation (New York) as ENZECOTM
Lactase NL 2.5X. The yeast neutral lactase may be added to the intermediate aqueous solution at a concentration of between 1 and 50 LU per gram of lactose in the intermediate aqueous solution. The yeast neutral lactase may be added to the intermediate aqueous solution at a concentration of about 4 to about 5 LU/g lactose in the intermediate aqueous solution. The yeast neutral lactase may be added to the intermediate aqueous solution at a concentration of about 4.7 LU per gram of lactose in the intermediate aqueous solution. The yeast neutral lactase may be added to the intermediate aqueous solution at a concentration of about 4.4 LU per gram of lactose in the intermediate aqueous solution.
Nevertheless, the skilled person will understand that the methods disclosed herein may be performed with a wide range of yeast lactase concentrations depending on a number of factors including the initial concentration of lactose in the intermediate aqueous solution, the length of time for which the reaction is allowed to proceed, the pH, and the reaction temperature.
-14-In certain embodiments, e.g. where the neutral yeast p-D-galactoside galactohydrolase is derived from a Kluyveromyces species, it may be necessary to add potassium and magnesium for enzyme activity. In embodiments where the pH must be adjusted up to 5.5 or higher, e.g. where the pH of the intermediate aqueous solution has been adjusted to about 2.0 or zero or less to deactivate the acid fungal lactase, the pH and salt can be adjusted using potassium, magnesium chloride, and citric acid.
ENZECOTM Lactase NL 2.5X has a pH optimum of about 6 to about 7.
Accordingly, the skilled person will understand that it may be necessary to adjust the pH of the intermediate aqueous solution between 6 and 7.5 to facilitate the activity of the neutral yeast lactase. In particular embodiments, adjusting pH of the intermediate solution with potassium hydroxide, magnesium chloride and citric acid involves adjusting the pH to about 6.8.
Such pH adjustments can lead to turbidity of the mixture, which can plug downstream separation equipment. However, this turbidity can largely be avoided by adding the salts in a specific sequence. More particularly, adjusting the pH of the intermediate aqueous solution to the desired pH and salt concentration by sequentially adding the potassium hydroxide, magnesium chloride and citric acid can avoid turbidity. More particularly, sequentially adding potassium hydroxide, magnesium chloride and citric acid to the intermediate aqueous solution in the following amount and order can largely avoid turbidity:
= adding potassium hydroxide to arrive at a pH of about 9.2;
= adding magnesium chloride to arrive at a pH of about 9.1; and = adding citric acid to a pH of about 6.8.
The temperature of the intermediate aqueous solution is adjusted to between 30 and 45 C prior to addition of the neutral yeast lactase. However, the skilled
-15-person will understand that while temperature may be adjusted for optimal enzyme activity, the yeast lactase may perform at a much slower rate outside this range, e.g. between about 4.0 and about 50.0 C. In particular embodiments disclosed herein, the temperature of the intermediate aqueous solution is adjusted to about 36.5 C for incubation with the neutral yeast lactase. As with the acid fungal lactase, the reaction time will depend on temperature, pH, lactase concentration, and initial concentration of lactose in the intermediate aqueous solution. Again, the reaction rate can be increased if enzyme cost is not a concern. Alternatively, the reactions may be run more slowly to save on the cost of enzyme.
The intermediate aqueous solution is incubated with the neutral yeast lactase to produce a final aqueous solution in which the concentration of lactose is between zero and about 20% of the initial concentration of lactose in the initial aqueous solution. In some embodiments, the intermediate aqueous solution is incubated with the neutral yeast lactase until a final aqueous solution comprising 23.5 % to 25% DP2 sugar (w/w) of total sugar in the final aqueous solution is achieved.
Deactivation of the Yeast Lactase Once a final concentration of between zero and 20% of the initial concentration of lactose and the initial aqueous solution has been achieved, the neutral yeast lactase may be deactivated. In some embodiments, deactivating the neutral yeast lactase involves adjusting the pH of the final aqueous solution to about pH 5.5, at or below which pH the enzyme effectively has no activity. In addition to adjusting the pH to 5.5, or as an alternative to adjusting pH to 5.5, deactivating the yeast lactase may involve incubating the final aqueous solution at 72 C. The necessity of the pH
adjustment step may depend on how quickly the final aqueous solution can be heated, and how quickly the reaction is proceeding prior to such heat treatment. If heating can be accomplished quickly enough so that there is no change in sugar composition (e.g. hydrolysis of GOS) while the final aqueous solution is being heated, then a pH adjustment may be unnecessary. On the
-16-other hand, the skilled person will appreciate that it may be unnecessary to heat treat the final aqueous solution to deactivate the neutral yeast lactase if pH is used to deactivate the reaction, the reaction rate is very slow, or the enzyme a little to no activity remaining.
Separation Chromatography may then be used to remove the enzymes, stabilizing agents, glucose and galactose from the final aqueous solution to produce a GOS-enriched solution. Ion exchange chromatography may be initially carried out on the final aqueous solution to remove the lactase enzymes, cations, anions, and components contributing to color.
After ion exchange, the further separation may be conducted to partially remove glucose and galactose and enrich the GOS fraction. The skilled person will be aware of the standard methods that may be available, including ion exchange, filtration, chromatographic separation (SMB), or additional fermentation reactions.
For example, simulated moving bed chromatography may be used to enrich the GOS in the GOS syrup from about 40% w/w of total carbohydrate in the final aqueous solution to greater than 60% w/w of total carbohydrates after separation.
GOS Products The composition of different GOS species in a GOS syrup is unpredictable and will depend on the specific lactase with which lactose solution is incubated, the concentration of lactose, and the concentration of lactose.
Accordingly, the skilled person will appreciate that the GOS syrups disclosed herein have a unique balance of di- (DP2), tri- (DP3), tetra- (DP4), penta-(DP5) and higher GOS. Accordingly, this disclosure also relates to GOS
syrups with novel GOS balances that are produced according to methods disclosed herein.
-17-Accordingly, this disclosure further relates to use of the combination of a first p-D-galactoside galactohydrolase derived from an Aspergillus oryzae with a second p-D-galactoside galactohydrolase derive from a Kluyveromyces lactis in the preparation of GOS syrup from an aqueous solution comprising lactose.
The GOS syrup may comprise at least 40% GOS w/w of total carbohydrate in the GOS syrup. The use involves incubation of the aqueous solution with the first 13-D-galactoside galactohydrolase followed by incubation with the second p-D-galactoside galactohydrolase.

An aqueous solution of edible lactose with a starting concentration of 45 Bx as adjusted to pH=5 using hydrochloric acid and equilibrated to 53.5 C. p-D-galactoside galactohydrolase derived from Aspergillus oryzae (ENZECOTM
Fungal Lactase Concentrate from Enzyme Development Company) was added to the aqueous solution to a concentration of 280 LU per gram of lactose in the aqueous solution. The initial aqueous solution was incubated with the p-D-galactoside galactohydrolase derived from Aspergillus oryzae for 195 minutes under constant agitation. Samples of the aqueous solution were taken at 1 min, 2.5 min, 5 min, 10 min, 15 min, 20 min, 25 min, 30 min, 40 min, 50 min, 60, min, 75 min, 90 min, 120 min, and 195 min. The composition of the carbohydrate fractions of the aqueous solution at the different time points are indicated in Table 1.

4.5 kg of edible lactose was suspended in 5.5 kg of water. The temperature of the suspension was brought to above 90 C under constant agitation until the lactose was completely dissolved to produce an initial aqueous solution.
The pH of the initial aqueous solution was adjusted to about 4.5 using
-18-hydrochloric acid. The temperature of the initial aqueous solution was equilibrated to 55 C. p-D-galactoside galactohydrolase derived from Aspergillus oryzae (ENZECOTm Fungal Lactase Concentrate from Enzyme Development Company) was added to the initial aqueous solution to a concentration of 20 LAU/g lactose. The initial aqueous solution was incubated with the 13-D-galactoside galactohydrolase derived from Aspergillus oryzae for 6 hours under constant agitation. The p-D-galactoside galactohydrolase was then deactivated by adjusting the pH to about 2.0 with HCI.
The resulting intermediate solution comprising of GOS, glucose, galactose, and unreacted lactose, was analyzed by HPLC to ensure that the lactose concentration was reduced to less than 60% of the initial concentration of lactose in the initial aqueous solution (see Figure 1, Table 2).
The pH of the intermediate solution was adjusted to about pH 8 with 50%
KOH. The pH of the intermediate solution was then adjusted to 6.75 with a salt solution comprising of 3.72% w/w citric acid, 6.01% w/w magnesium chloride hexahydrate, and 15.55% w/w dipotassium hydrogen phosphate. 13-D-galactoside galactohydrolase derived from Kluyveromyces lactis (ENZECOTm Lactase NL 2.5x from Enzyme Development Company) was then added at a dosage of 8.8 LAU/g lactose. The intermediate solution was incubated with p-D-galactoside galactohydrolase derived from Kluyveromyces lactis for 10 hours under constant agitation. The p-D-galactoside galactohydrolase derived from Kluyveromyces lactis was then deactivated by adjusting the pH to about 3.0 with HCI.

ao Table 1. GOS produced using lactase (280 LU/g lactose) from Aspergillus Oryzae (Enzeco Fungal lactase) at starting lactose of 45 BRIX, T=53.5C, pH =5.
Time (min) 1 2.5 5 10 15 20 25 30 40 50 60 DP5+
0.063 0.286 0.790 1.601 2.250 2.634 2.877 3.009 3.155 3.134 3.001 2.867 2.671 2.210 1.320 1.143 2.594 4.288 5.821 6.449 6.605 6.669 6.522 6.299 6.051 5.649 5.247 4.917 4.214 2.957 12.532 16.610 18.862 19.508 18.954 18.265 17.792 17.223 16.197 15.652 14.742 13.831 13.053 11.815 9.206 Lactose 78.856 69.258 57.818 48.774 42.769 38.460 35.558 33.051 28.909 26.122 23.476 20.830 18.760 15.493 10.976 0.532 0.382 2.339 2.913 4.257 5.630 6.342 7.100 8.657 9.674 10.650 11.626 12.136 13.289 13.673 Glucose 5.881 9.039 12.695 16.687 19.316 21.209 22.778 24.148 26.257 27.719 29.345 30.970 32.289 34.402 38.059 Galactose 0.993 1.830 3.207 4.697 6.004 7.197 7.984 8.947 10.526 11.648 13.138 14.629 16.174 18.578 23.810 TOTAL
GOS
14.271 19.872 26.280 29.843 31.910 33.134 33.680 33.854 34.308 34.510 34.041 33.572 32.777 31.528 27.155 Table 2. % Composition of sugars in GOS mixture following primary transgalactosylation of lactose using fungal p-galactosidase from Aspergillus oryzae carbohydrate % w/w of the total carbohydrate DP6 0.495 DP5 1.884 DP4 6.505 DP3 19.050 DP2 4.005 Lactose 42.348 Glucose 19.634 Galactose 6.079 TOTAL GOS 31.939 The resulting final aqueous solution comprising of GOS, glucose, galactose and unreacted lactose, was analyzed by HPLC to ensure that the lactose concentration was to 10% or less than the initial concentration of lactose in the initial solution (see Figure 2, Table 3).
Table 3. %Composition of sugars in GOS mixture following secondary transgalactosylation of lactose using yeast 13-galactosidase from Kluyveronnyces carbohydrate % w/w of the total carbohydrate DP6+ 0.435 DP5 1.908 DP4 6.742 DP3 18.580 DP2 12.842 Lactose 8.733 Glucose 33.67 Galactose 17.082 TOTAL GOS 40.506 Demineralized, deproteinized, ultrafiltered milk permeate was evaporated to 35 Bx, and incubated with p-D-galactoside galactohydrolases derived from Aspergillus oryzae and Kluyveromyces lacti as described in Example 2. The composition of sugars in the GOS mixture following two-stage transgalactosylation of lactose from ultrafiltered milk permeate is shown in Table 4.
Table 4. % Composition of sugars in GOS mixture following two-stage transgalactosylation of lactose from ultrafiltered milk permeate using yeast p-galactosidase from Aspergillus Oryzae and Kluyveromyces Lactis.
Name % w/w of the total carbohydrate DP5+ 1.328 DP4 6.094 DP3 18.143 DP2 15.475 Lactose 8.523 Glucose 33.973 Galactose 16.464 TOTAL GOS 41.040 27.4 kg of edible lactose was suspended in 20.8 kg of water to produce a solution of 54 Bx. The temperature of the suspension was brought to above 95 C under constant agitation until the lactose was completely dissolved to produce an initial aqueous solution. The pH of the initial aqueous solution was 5.4. The temperature of the initial aqueous solution was equilibrated to 58.5 C. p-D-galactoside galactohydrolase derived from Aspergillus oryzae (ENZECOTm Fungal Lactase Concentrate from Enzyme Development Company) was added to the initial aqueous solution to a concentration of 277 LU/g lactose. The initial aqueous solution was incubated with the p-D-galactoside galactohydrolase derived from Aspergillus oryzae for 15 minutes under constant agitation. The p-D-galactoside galactohydrolase was then deactivated by adjusting the pH to about 2.0 with HCI.

The resulting intermediate solution comprising of GOS, glucose, galactose, and unreacted lactose, was analyzed by HPLC to ensure that the lactose concentration was reduced to less than 60% of the initial concentration of lactose in the initial aqueous solution (see Table 5).
The intermediate solution was diluted to 50BRIX. The pH was adjusted to about pH 9.3 with 50% KOH. Magnesium chloride hexahydrate (25g) was added and the pH adjusted to 6.80 using 50% citric acid. p-D-galactoside galactohydrolase derived from Kluyveromyces lactis (ENZECOTM Lactase NL
2.5x from Enzyme Development Company) was then added at a dosage of 40.4 LU/g lactose. The temperature of the solution was adjusted to 40 C.
The intermediate solution was incubated with p-D-galactoside galactohydrolase derived from Kluyveromyces lactis for 100 minutes under constant agitation. The p-D-galactoside galactohydrolase derived from Kluyveromyces lactis was then deactivated by adjusting the pH to about 3.0 with HCI.
Table 5. % Composition of sugars in GOS mixture following primary transgalactosylation of lactose using fungal 13-galactosidase from Aspergillus oryzae Name % w/w of the total carbohydrate DP6 0.397 DP5 1.812 DP4 6.795 DP3 19.773 DP2 3.216 Lactose 43.655 Glucose 18.875 Galactose 5.478 TOTAL GOS 31.595 The resulting final aqueous solution comprising of GOS, glucose, galactose and unreacted lactose, was analyzed by HPLC (see Table 6).

Table 6. % Composition of sugars in GOS mixture following secondary transgalactosylation of lactose using yeast I3-galactosidase from Kluyveromyces Name % w/w of the total carbohydrate DP6+ 0.380 DP5 1.840 DP4 6.892 DP3 19.302 DP2 13.403 Lactose 8.691 Glucose 32.573 Galactose 16.919 TOTAL GOS 41.817 Edible crystalline lactose (Lynn Proteins, Inc., Granton, WI) was dissolved in water at 90 C to a final concentration of 45913x to produce an initial aqueous solution of lactose. The temperature of the initial lactose solution was equilibrated to about 53.5C, and the pH was adjusted to between 4.5 and 5.0 using HCI. Fungal p-D-galactoside galactohydrolase derived from Aspergfflus oryzae (ENZECOTM Fungal Lactase Concentrate from Enzyme Development Company) was then added to the initial aqueous solution to a concentration of 5.6 LU/g of lactose. The solution was incubated 17 hours under constant agitation to produce an intermediate aqueous solution comprising lactose at a concentration about 40% of the initial concentration of lactose in the initial aqueous solution. The fungal p-D-galactoside galactohydrolase was then deactivated by adjusting the pH to about 2.0 with HCI using a 15% w/w aqueous solution of HCI. After 60 minutes of steady agitation, a 50% w/w solution of KOH was slowly added to the intermediate aqueous solution, thereby adjusting the pH to about 9.30. A 25% w/v solution of magnesium chloride hexahydrate was then added to a concentration of 0.16% w/w of the intermediate aqueous solution, thereby adjusting the pH to about 9.21. Then, a 50% solution of citric acid was slowly added to the intermediate aqueous solution until the pH reached about 6.8. The intermediate aqueous solution was then equilibrated to 36.5 C. Yeast pi-D-galactoside galactohydrolase derived from Kluyveromyces lactis (ENZECOTm Lactase NL 2.5x from Enzyme Development Company) was then added to a concentration of 4.7 LU/g of lactose to the intermediate aqueous solution. The intermediate aqueous solution was incubated for 17h under steady agitation to produce a final aqueous solution comprising lactose at a concentration less than 20% of the lactose concentration in the initial aqueous solution. The pH of the final aqueous solution was adjusted to pH 5.5 with citric acid to deactivate the 13-o-galactoside galactohydrolase derived from Kluyveromyces lactis. The final aqueous solution was then heat treated at 72 C for 15 seconds. The carbohydrate composition of the final aqueous solution from five trials is provided in Table 7.
The final aqueous solution was subjected to ion exchange purification to remove the salts, lactase enzymes and color components. After ion exchange, the partially purified solution was subjected to a purification step to enrich the GOS fraction. The carbohydrate composition of the GOS syrup final aqueous solution from five trials is provided in Table 7.
Table 7. Carbohydrate composition of GOS syrup produced using a combination of lactases from Aspergillus oryzae and Kluyveromyces lactis prior to chromatographic separation.
% w/w of the total carbohydrate Name Stage 1 (t=17h) Stage 2 (t=17h) Enrichment DP6 0.450 0.396 0.683 DP5 1.973 1.743 2.946 DP4 6.743 6.638 11.133 DP3 18.770 18.851 32.972 DP2 4.069 12.652 18.216 Lactose 40.792 8.830 14.891 DP2 + Lactose 44.861 21.482 88.107 Glucose 20.581 33.526 17.346 Galactose 6.622 17.364 1.814 TOTAL GOS 32.006 40.280 65.950 Edible crystalline lactose (Lynn Proteins, Inc., Granton, WI) was dissolved in water at 95 C to a final concentration of 53 Bx to produce an initial aqueous solution of lactose. The temperature of the initial lactose solution was equilibrated to about 55-56.5 C, and the pH was adjusted to between 4.5 and 5.5. Fungal p-D-galactoside galactohydrolase derived from Aspergillus oryzae (ENZECOTm Fungal Lactase Concentrate from Enzyme Development Company) was then added to the initial aqueous solution to a concentration of 5.8 LU/g of lactose. The solution was incubated 11 hours under constant agitation to produce an intermediate aqueous solution comprising lactose at a concentration about 40% of the initial concentration of lactose in the initial aqueous solution, and DP2 sugar at 49% to 52% of total sugar. Thus, increasing the initial lactose concentration and enzyme concentration reduced the required reaction time from 17 h to 11 h. The fungal p-D-galactoside galactohydrolase was then deactivated by adjusting the pH to about 2.0 with HCI using a 15% w/w aqueous solution of HCI. a 20% w/w solution of KOH
was slowly added to the intermediate aqueous solution, thereby adjusting the pH to about 9.30. A 25% w/v solution of magnesium chloride hexahydrate was then added to a concentration of 0.16% w/w of the intermediate aqueous solution, thereby adjusting the pH to about 9.21, and essential ions were added to the second enzymatic reaction. Then, a 20% solution of citric acid was slowly added to the intermediate aqueous solution until the pH reached about 6.8. The intermediate aqueous solution was then equilibrated to 36.5 C.
Yeast p-D-galactoside galactohydrolase derived from Kluyveromyces lactis (ENZECOTm Lactase NL 2.5x from Enzyme Development Company) was then added to a concentration of 4.4 LU/g of lactose to the intermediate aqueous solution. The intermediate aqueous solution was incubated for 17h under steady agitation to produce a final aqueous solution comprising lactose at a concentration less than 20% of the lactose concentration in the initial aqueous solution, and DP2 sugar at 23.5% to 25% of total sugar). The final aqueous solution was then heat treated at 72 C for 15 seconds to deactivate the p-D-galactoside galactohydrolase derived from Kluyveromyces lactis. The carbohydrate composition of the final aqueous solution from ten trials is provided in Table 8.
The final aqueous solution was subjected to ion exchange purification to remove the salts, lactase enzymes and color components. After ion exchange, the partially purified solution was subjected to a purification step to enrich the GOS fraction. The carbohydrate composition of the GOS syrup final aqueous solution from five trials is provided in Table 8.
Table 8 Carbohydrate composition of GOS syrup produced using a combination of lactases from Aspergillus oryzae and Kluyveromyces lactis prior to chromatographic separation.
% w/w of the total carbohydrate Name Stage 1 (t=1 1 h) Stage 2 (t=1 7h) Enrichment DP6 0.172 0.051 0.187 0.044 0.278 0.033 DP5 1.407 0.085 1.574 0.112 2.237 0.136 DP4 6.165 0.144 6.851 0.254 10.126 0.433 DP3 19.816 + 0.691 20.042 0.524 30.882 0.748 DP2 with lactose 50.564 + 0.504 23.821 0.783 35.460 0.838 Glucose 17.247 + 0.553 32.108 0.640 18.624 0.939 Galactose 4.623 0.565 15.416 0.537 2.393 0.607 TOTAL GOS 64.531 1.463 While specific embodiments of the invention have been described and illustrated, such embodiments should be considered illustrative of the invention only and not as limiting the invention as construed in accordance with the accompanying claims.

Claims (174)

What is claimed is:
1. A method of producing galactooligosaccharide (GOS) from lactose, the method comprising:
incubating an initial aqueous solution comprising lactose at an initial concentration with an acid lactase, wherein the acid lactase is an acid .beta.-D-galactoside galactohydrolase derived from Aspergillus oryzae, to produce an intermediate aqueous solution comprising lactose and GOS in which the concentration of lactose is about 30% to about 70% of the initial concentration of the initial aqueous solution, and in which DP2 sugar is about 49% to about 52% by weight of total sugar in the intermediate aqueous solution;
adjusting the intermediate aqueous solution, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0;
adding a neutral lactase to the intermediate aqueous solution, wherein the neutral lactase is a neutral .beta.-D-galactoside galactohydrolase derived from a Kluyveromyces lactis; and incubating the intermediate aqueous solution comprising the neutral lactase to produce a final aqueous solution in which the concentration of lactose is about 20% or less of the initial concentration of the initial aqueous solution.
2. The method of claim 1, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH with KOH.
3. The method of claim 1 or 2, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises initially adjusting the pH
to about 9.2 with KOH.
4. The method of claim 1, 2, or 3, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH with citric acid.
5. The method of claim 3, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises, subsequent to adjusting the pH to about 9.2 with KOH, adjusting the pH to between 5.5 and 9.0 with citric acid.
6. The method of claim 3, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises, subsequent to adjusting the pH to about 9.2 with KOH, adjusting the pH to about 6.8 with citric acid.
7. The method of any one of claims 1 to 5, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH to between 6.0 and 7.5.
8. The method of any one of claims 1 to 5, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH to about 6.8.
9. The method of any one of claims 1 to 8, wherein adjusting the intermediate aqueous solution further comprises adjusting the salt content of the intermediate aqueous solution with MgCl2.
10. The method of claim 9, wherein adjusting the salt content of the intermediate aqueous solution with MgCl2 comprises adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution.
11. The method of any one of claims 1 to 8, wherein adjusting the intermediate aqueous solution comprises sequentially adding KOH and MgCl2 to the intermediate aqueous solution.
12. The method of claim 11, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to about 9.2 with KOH and adding about 0.16 g of MgCl2 per, 100 g of aqueous solution to the intermediate aqueous solution.
13. The method of any one of claims 1 to 4, wherein adjusting the intermediate aqueous solution comprises sequentially adding KOH and citric acid to the intermediate aqueous solution.
14. The method of claim 13, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to about 9.2 with KOH and, subsequently, adjusting the pH of the intermediate aqueous solution to about 6.8 with citric acid.
15. The method of any one of claims 1 to 14, wherein adjusting the intermediate aqueous solution further comprises sequentially adding MgCl2 and citric acid to the intermediate aqueous solution.
16. The method of claim 15, wherein adjusting the intermediate aqueous solution comprises adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution and adjusting the pH of the intermediate aqueous solution to about 6.8 with citric acid.
17. The method of any one of claims 1 to 8, wherein adjusting the intermediate aqueous solution comprises sequentially adding KOH, MgCl2, and citric acid to the intermediate aqueous solution.
18. The method of claim 17, wherein sequentially adding KOH, MgCl2, and citric acid to the intermediate aqueous solution comprises, in sequential order:
adjusting the pH of the intermediate aqueous solution to about 9.2 with KOH;
adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution; and adjusting the pH of the intermediate aqueous solution to about 6.8.
19. The method of any one of claims 1 to 18, wherein the concentration of the acid lactase in the initial aqueous solution is between 1 and 300 lactase units (LU) per gram of lactose in the initial aqueous solution.
20. The method of any one of claims 1 to 19, wherein the concentration of the acid lactase in the initial aqueous solution is about 5.6 LU per gram of lactose in the initial aqueous solution.
21. The method of any one of claims 1 to 19, wherein the concentration of the acid lactase in the initial aqueous solution is about 5.7 LU per gram of lactose in the initial aqueous solution.
22. The method of any one of claims 1 to 19, wherein the concentration of the acid lactase in the initial aqueous solution is about 5.8 LU per gram of lactose in the initial aqueous solution.
23. The method of any one of claims 1 to 22, wherein adding the neutral lactase to the intermediate aqueous solution comprises adding the neutral lactase to a concentration of between 1 and 50 lactase units (LU) per gram of lactose in the intermediate aqueous solution.
24. The method of any one of claims 1 to 22, wherein adding the neutral lactase to the intermediate aqueous solution comprises adding the neutral lactase to a concentration of about 4.4 LU per gram of lactose in the intermediate aqueous solution.
25. The method of any one of claims 1 to 22, wherein adding the neutral lactase to the intermediate aqueous solution comprises adding the neutral lactase to a concentration of about 4.5 LU per gram of lactose in the intermediate aqueous solution.
26. The method of any one of claims 1 to 22, wherein adding the neutral lactase to the intermediate aqueous solution comprises adding the neutral lactase to a concentration of about 4.6 LU per gram of lactose in the intermediate aqueous solution.
27. The method of any one of claims 1 to 22, wherein adding the neutral lactase to the intermediate aqueous solution comprises adding the neutral lactase to a concentration of about 4.7 LU per gram of lactose in the intermediate aqueous solution.
28. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is between 15 and 63 Bx.
29. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is about 15 Bx.
30. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is about 63 Bx.
31. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is in a range of 30 Bx to 60 Bx.
32. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is about 30 Bx.
33. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is about 60 Bx.
34. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is about 45 Bx.
35. The method of any one of claims 1 to 27, wherein the initial concentration of lactose in the initial aqueous solution is about 53 Bx.
36. The method of any one of claims 1 to 35, wherein the initial aqueous solution is incubated to produce an intermediate aqueous solution comprising about 40% of the initial concentration of lactose in the initial aqueous solution.
37. The method of any one of claims 1 to 35, wherein the initial aqueous solution is incubated to produce an intermediate aqueous solution comprising about 30% to about 40% of the initial concentration of lactose in the initial aqueous solution.
38. The method of any one of claims 1 to 37, wherein the initial aqueous solution is incubated with the acid lactase until the aqueous solution comprises about 49%

sugar by weight of total sugar in the intermediate aqueous solution.
39. The method of any one of claims 1 to 37, wherein the initial aqueous solution is incubated with the acid lactase until the aqueous solution comprises about 52%

sugar by weight of total sugar in the intermediate aqueous solution.
40. The method of any one of claims 1 to 39, wherein the intermediate aqueous solution is incubated with the neutral lactase until DP2 sugar is 23.5% to 25%
DP2 of total sugar by weight.
41. The method of any one of claims 1 to 39, wherein the intermediate aqueous solution is incubated with the neutral lactase until DP2 sugar is about 23.5%
of total sugar by weight.
42. The method of any one of claims 1 to 39, wherein the intermediate aqueous solution is incubated with the neutral lactase until DP2 sugar is about 25% of total sugar by weight.
43. The method of any one of claims 1 to 42, wherein, the initial aqueous solution is incubated with the acid lactase at a temperature between about 25 and about 75°C.
44. The method of any one of claims 1 to 42, wherein the initial aqueous solution is incubated with the acid lactase at a temperature between about 35 and about 65°C.
45. The method of any one of claims 1 to 44, wherein the initial aqueous solution is incubated with the acid lactase at a temperature between about 50 and about 55°C.
46. The method of any one of claims 1 to 44, wherein the initial aqueous solution is incubated with the acid lactase at a temperature of about 53.5°C.
47. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH in a range of 2.5 to 6.5.
48. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH of about 2.5.
49. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH in a range of 4.5 to 5Ø
50. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH in a range of 3.5 to 6.5.
51. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH of about 3.5.
52. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH of about 6.5.
53. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH in a range of 4.5 to 5.5.
54. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH of about 4.5.
55. The method of any one of claims 1 to 46, wherein the initial aqueous solution is incubated with the acid lactase at a pH of about 5.5.
56. The method of any one of claims 1 to 55, comprising deactivating the acid lactase prior to adding the neutral lactase.
57. The method of claim 56, wherein deactivating the acid lactase comprises adjusting the pH of the intermediate aqueous solution to about 2 or less.
58. The method of claim 56, wherein deactivating the acid lactase comprises adjusting the pH of the intermediate aqueous solution to about 2.
59. The method of any one of claims 1 to 58, wherein the pH of the intermediate aqueous solution is adjusted with hydrochloric acid to deactivate the acid lactase.
60. The method of any one of claims 1 to 59, wherein the intermediate aqueous solution is incubated with the neutral lactase at a temperature between about 4°C and about 50°C.
61. The method of any one of claims 1 to 59, wherein the intermediate aqueous solution is incubated with the neutral lactase at a temperature between about 30°C
and about 45°C.
62. The method of any one of claims 1 to 59, wherein the intermediate aqueous solution is incubated with the neutral lactase at a temperature of about 36.5°C.
63. The method of any one of claims 1 to 62, further comprising deactivating the neutral lactase.
64. The method of claim 63, wherein deactivating the neutral lactase comprises adjusting the pH of the final aqueous solution to about pH 5.5 or lower.
65. The method of claim 64, comprising adjusting the pH of the final aqueous solution to about pH 5.5 with citric acid.
66. The method of claim 63, 64, or 65, wherein deactivating the neutral lactase comprises incubating the final aqueous solution at 72°C.
67. The method of any one of claims 1 to 66, further comprising removing galactose and/or glucose from the final aqueous solution by ion exchange, filtration, chromatographic separation, or additional fermentation reactions.
68. The method of claim 67, wherein chromatographic separation comprises simulated moving bed chromatography.
69. Use of an acid lactase in combination with a neutral lactase in the preparation of galactooligosaccharide (GOS) syrup from an aqueous mixture comprising lactose, wherein the GOS syrup comprises at least about 40% GOS w/w of the total carbohydrate in the GOS syrup, and wherein the GOS syrup comprises about 23.5%

to about 25% DP2 sugar by weight of total sugar in the aqueous solution.
70. The use of claim 69, wherein the acid lactase is an acid .beta.-D-galactoside galactohydrolase.
71. The use of claim 69 or 70, wherein the acid lactase is derived from an Aspergillus species.
72. The use of claim 69 or 70, wherein the acid lactase is derived from Aspergillus oryzae.
73. The use of any one of claims 69 to 72, wherein the acid lactase is for use at concentration of between 1 and 300 lactase units (LU) per gram of lactose in the aqueous mixture.
74. The use of any one of claims 69 to 72, wherein the acid lactase is for use at a concentration in the aqueous mixture of about 5.6 LU per gram of lactose in the aqueous mixture.
75. The use of any one of claims 69 to 72, wherein the acid lactase is for use at a concentration in the aqueous mixture of about 5.7 LU per gram of lactose in the aqueous mixture.
76. The use of any one of claims 69 to 72, wherein the acid lactase is for use at a concentration in the aqueous mixture of about 5.8 LU per gram of lactose in the aqueous mixture.
77. The use of any one of claims 69 to 72, wherein the neutral lactase is a neutral .beta.-D-galactoside galactohydrolase.
78. The use of any one of claims 69 to 77, wherein the neutral lactase is derived from a Kluyveromyces species.
79. The use of any one of claims 69 to 77, wherein the neutral lactase is derived from Kluyveromyces lactis.
80. The use of any one of claims 69 to 79, wherein the neutral lactase is for use at a concentration in the aqueous mixture of between 1 and 50 lactase units (LU) per gram of lactose in the aqueous mixture.
81. The use of any one of claims 69 to 79, wherein the neutral lactase is for use at a concentration in the aqueous mixture of about 4.4 LU per gram of lactose in the aqueous mixture.
82. The use of any one of claims 69 to 79, wherein neutral lactase is for use at a concentration in the aqueous mixture of about 4.5 LU per gram of lactose in the aqueous mixture.
83. The use of any one of claims 69 to 79, wherein neutral lactase is for use at a concentration in the aqueous mixture of about 4.6 LU per gram of lactose in the aqueous mixture.
84. The use of any one of claims 69 to 79, wherein neutral lactase is for use at a concentration in the aqueous mixture of about 4.7 LU per gram of lactose in the aqueous mixture.
85. The use of any one of claims 69 to 84, wherein the acid lactase is for incubation with the aqueous mixture prior to incubation of the aqueous mixture with the neutral lactase.
86. The use of any one of claims 69 to 85, wherein the GOS syrup comprises at least about 60% GOS w/w of the total carbohydrate in the GOS syrup.
87. The use of any one of claims 69 to 85, wherein the GOS syrup comprises about 65% GOS w/w of the total carbohydrate in the GOS syrup.
88. A method of minimizing the turbidity of a reaction mixture comprising a solution comprising lactose and galactoligosaccharides as it is adjusted from a pH of about 4.5 to 5.5 for incubation with a neutral lactase at a pH of about 6.0 to about 7.5, the method comprising, in sequential order:
adjusting the pH of the solution to about 9.2 with KOH;
adding about 0.16 g of MgCl2 per 100 g of the solution to the intermediate aqueous solution; and adjusting the pH of the solution with an acid to between about 6.0 and about 7.5.
89. A method of minimizing the turbidity of a reaction mixture comprising a solution comprising lactose and galactoligosaccharides as it is adjusted from basic pH
toward a neutral pH for incubation with a neutral lactase, the method comprising adjusting a salt concentration of the solution with MgCl2 before adding an acid to reduce the pH toward the neutral pH.
90. The method of claim 89, wherein the basic pH is about 9.2.
91. The method of claim 89 or 90, wherein adjusting the salt concentration with MgCl2 comprises adding about 0.16 g of MgCl2 per 100 g of the solution.
92. The method of claim 89, 90, or 91, wherein adding the acid to reduce the pH
toward the neutral pH comprises adding the acid to reduce the pH to between about 6.0 and about 7.5.
93. The method of any one of claims 89 to 92, wherein the acid is citric acid.
94. A method of producing galactooligosaccharide (GOS) from lactose, the method comprising:
incubating an initial aqueous solution comprising lactose at an initial concentration with an acid .beta.-D-galactoside galactohydrolase derived from Aspergillus maw to produce an intermediate aqueous solution comprising lactose and GOS in which the concentration of lactose is about 30% to about 70% of the initial concentration of the initial aqueous solution;
adjusting the intermediate aqueous solution, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0;
adding neutral .beta.-D-galactoside galactohydrolase derived from Kluyveromyces lactis to the intermediate aqueous solution; and incubating the intermediate aqueous solution comprising the neutral .beta.-D-galactoside galactohydrolase until DP2 sugar is about 23.5% to 25% of total sugar by weight to produce a final aqueous solution in which the concentration of lactose is about 20% or less of the initial concentration of the initial aqueous solution.
95. The method of claim 94, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH with KOH.
96. The method of claim 94 or 95, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises initially adjusting the pH
to about 9.2 with KOH.
97. The method of claim 94, 95, or 96, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH with citric acid.
98. The method of claim 96, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises, subsequent to adjusting the pH to about 9.2 with KOH, adjusting the pH to between 5.5 and 9.0 with citric acid.
99. The method of claim 96, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises, subsequent to adjusting the pH to about 9.2 with KOH, adjusting the pH to about 6.8 with citric acid.
100. The method of any one of claims 94 to 98, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH to between 6.0 and 7.5.
101. The method of any one of claims 94 to 98, wherein adjusting the pH of the intermediate aqueous solution to between 5.5 and 9.0 comprises adjusting the pH to about 6.8.
102. The method of any one of claims 94 to 101, wherein adjusting the intermediate aqueous solution comprises adjusting the salt content of the intermediate aqueous solution with MgCl2.
103. The method of claim 102, wherein adjusting the salt content of the intermediate aqueous solution with MgCl2 comprises adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution.
104. The method of any one of claims 94 to 101, wherein adjusting the intermediate aqueous solution comprises sequentially adding KOH and MgCl2 to the intermediate aqueous solution.
105. The method of claim 104, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to about 9.2 with KOH and adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution.
106. The method of any one of claims 94 to 97, wherein adjusting the intermediate aqueous solution comprises sequentially adding KOH and citric acid to the intermediate aqueous solution.
107. The method of claim 106, wherein adjusting the intermediate aqueous solution comprises adjusting the pH of the intermediate aqueous solution to about 9.2 with KOH and, subsequently, adjusting the pH of the intermediate aqueous solution to about 6.8 with citric acid.
108. The method of any one of claims 94 to 107, wherein adjusting the intermediate aqueous solution comprises sequentially adding MgCl2 and citric acid to the intermediate aqueous solution.
109. The method of claim 108, wherein adjusting the intermediate aqueous solution comprises adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution and adjusting the pH of the intermediate aqueous solution to about 6.8 with citric acid.
110. The method of any one of claims 94 to 109, wherein adjusting the intermediate aqueous solution comprises sequentially adding KOH, MgCl2, and citric acid to the intermediate aqueous solution.
111. The method of claim 110, wherein sequentially adding KOH, MgCl2, and citric acid to the intermediate aqueous solution comprises, in sequential order:
adjusting the pH of the intermediate aqueous solution to about 9.2 with KOH;
adding about 0.16 g of MgCl2 per 100 g of aqueous solution to the intermediate aqueous solution; and adjusting the pH of the intermediate aqueous solution to about 6.8.
112. The method of any one of claims 94 to 111, wherein the concentration of the acid .beta.-D-galactoside galactohydrolase in the initial aqueous solution is between 1 and 300 .beta.-D-galactoside galactohydrolase units (LU) per gram of lactose in the initial aqueous solution.
113. The method of any one of claims 94 to 111, wherein the concentration of the acid .beta.-D-galactoside galactohydrolase in the initial aqueous solution is about 5.6 LU
per gram of lactose in the initial aqueous solution.
114. The method of any one of claims 94 to 111, wherein the concentration of the acid .beta.-D-galactoside galactohydrolase in the initial aqueous solution is about 5.7 LU
per gram of lactose in the initial aqueous solution.
115. The method of any one of claims 94 to 111, wherein the concentration of the acid .beta.-D-galactoside galactohydrolase in the initial aqueous solution is about 5.8 LU
per gram of lactose in the initial aqueous solution.
116. The method of any one of claims 94 to 115, wherein adding the neutral .beta.-D-galactoside galactohydrolase to the intermediate aqueous solution comprises adding the neutral .beta.-D-galactoside galactohydrolase to a concentration of between 1 and 50 .beta.-D-galactoside galactohydrolase units (LU) per gram of lactose in the intermediate aqueous solution.
117. The method of any one of claims 94 to 115, wherein adding the neutral .beta.-D-galactoside galactohydrolase to the intermediate aqueous solution comprises adding the neutral .beta.-D-galactoside galactohydrolase to a concentration of about 4.4 LU per gram of lactose in the intermediate aqueous solution.
118. The method of any one of claims 94 to 115, wherein adding the neutral .beta.-D-galactoside galactohydrolase to the intermediate aqueous solution comprises adding the neutral .beta.-D-galactoside galactohydrolase to a concentration of about 4.5 LU per gram of lactose in the intermediate aqueous solution.
119. The method of any one of claims 94 to 115, wherein adding the neutral .beta.-D-galactoside galactohydrolase to the intermediate aqueous solution comprises adding the neutral .beta.-D-galactoside galactohydrolase to a concentration of about 4.6 LU per gram of lactose in the intermediate aqueous solution.
120. The method of any one of claims 94 to 115, wherein adding the neutral .beta.-D-galactoside galactohydrolase to the intermediate aqueous solution comprises adding the neutral .beta.-D-galactoside galactohydrolase to a concentration of about 4.7 LU per gram of lactose in the intermediate aqueous solution.
121. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is between 15 and 63 Bx.
122. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is about 15 Bx.
123. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is about 63 Bx.
124. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is in a range of 30 Bx to 60 Bx.
125. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is about 30 Bx.
126. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is about 60 Bx.
127. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is about 45 Bx.
128. The method of any one of claims 94 to 120, wherein the initial concentration of lactose in the initial aqueous solution is about 53 Bx.
129. The method of any one of claims 94 to 128, wherein the initial aqueous solution is incubated to produce an intermediate aqueous solution comprising about 40%
of the initial concentration of lactose in the initial aqueous solution.
130. The method of any one of claims 94 to 128, wherein the initial aqueous solution is incubated to produce an intermediate aqueous solution comprising about 30%
to about 40% of the initial concentration of lactose in the initial aqueous solution.
131. The method of any one of claims 94 to 130, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase until the aqueous solution comprises 49% to 52% DP2 sugar by weight of total sugar in the intermediate aqueous solution.
132. The method of any one of claims 94 to 130, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase until the aqueous solution comprises about 49% DP2 sugar by weight of total sugar in the intermediate aqueous solution.
133. The method of any one of claims 94 to 130, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase until the aqueous solution comprises about 52% DP2 sugar by weight of total sugar in the intermediate aqueous solution.
134. The method of any one of claims 94 to 133, wherein the intermediate aqueous solution is incubated with the neutral .beta.-D-galactoside galactohydrolase until DP2 sugar is about 23.5% DP2 of total sugar by weight.
135. The method of any one of claims 94 to 133, wherein the intermediate aqueous solution is incubated with the neutral .beta.-D-galactoside galactohydrolase until DP2 sugar is about 25% of total sugar by weight.
136. The method of any one of claims 94 to 135, wherein, the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a temperature between about 25 and about 75°C.
137. The method of any one of claims 94 to 135, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a temperature between about 35 and about 65°C.
138. The method of any one of claims 94 to 135, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a temperature between about 50 and about 55°C.
139. The method of any one of claims 94 to 135, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a temperature of about 53.5°C.
140. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH in a range of 2.5 to 6.5.
141. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH of about 2.5.
142. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH in a range of 4.5 to 5.00.
143. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH in a range of 3.5 to 6.5.
144. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH of about 3.5.
145. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH of about 6.5.
146. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH in a range of 4.5 to 5.5.
147. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH of about 4.5.
148. The method of any one of claims 94 to 139, wherein the initial aqueous solution is incubated with the acid .beta.-D-galactoside galactohydrolase at a pH of about 5.5.
149. The method of any one of claims 94 to 148, comprising deactivating the acid .beta.-D-galactoside galactohydrolase prior to adding the neutral .beta.-D-galactoside galactohydrolase.
150. The method of claim 149, wherein deactivating the acid .beta.-D-galactoside galactohydrolase comprises adjusting the pH of the intermediate aqueous solution to about 2 or less.
151. The method of claim 149, wherein deactivating the acid .beta.-D-galactoside galactohydrolase comprises adjusting the pH of the intermediate aqueous solution to about 2.
152. The method of any one of claims 94 to 151, wherein the pH of the intermediate aqueous solution is adjusted with hydrochloric acid to deactivate the acid .beta.-D-galactoside galactohydrolase.
153. The method of any one of claims 94 to 152, wherein the intermediate aqueous solution is incubated with the neutral .beta.-D-galactoside galactohydrolase at a temperature between about 4°C and about 50°C.
154. The method of any one of claims 94 to 152, wherein the intermediate aqueous solution is incubated with the neutral .beta.-D-galactoside galactohydrolase at a temperature between about 30°C and about 45°C.
155. The method of any one of claims 94 to 152, wherein the intermediate aqueous solution is incubated with the neutral .beta.-D-galactoside galactohydrolase at a temperature of about 36.5°C.
156. The method of any one of claims 94 to 155, further comprising deactivating the neutral .beta.-D-galactoside galactohydrolase.
157. The method of claim 156, wherein deactivating the neutral .beta.-D-galactoside galactohydrolase comprises adjusting the pH of the final aqueous solution to about pH
5.5 or lower.
158. The method of claim 157, comprising adjusting the pH of the final aqueous solution to about pH 5.5 with citric acid.
159. The method of claim 156, 157, or 158, wherein deactivating the neutral .beta.-D-galactoside galactohydrolase comprises incubating the final aqueous solution at 72°C.
160. The method of any one of claims 94 to 159, further comprising removing galactose and/or glucose from the final aqueous solution by ion exchange, filtration, chromatographic separation, or additional fermentation reactions.
161. The method of claim 160, wherein chromatographic separation comprises simulated moving bed chromatography.
162. Use of an acid .beta.-D-galactoside galactohydrolase derived from Aspergillus oryzae in combination with a neutral .beta.-D-galactoside galactohydrolase derived from Kluyveromyces lactis in the preparation of galactooligosaccharide (GOS) syrup from an aqueous mixture comprising lactose, wherein the GOS syrup comprises at least about 40% GOS w/w of the total carbohydrate in the GOS syrup.
163. The use of claim 162, wherein the acid .beta.-D-galactoside galactohydrolase is for use at concentration of between 1 and 300 .beta.-D-galactoside galactohydrolase units (LU) per gram of lactose in the aqueous mixture.
164. The use of claim 162 or 163, wherein the acid .beta.-D-galactoside galactohydrolase is for use at a concentration in the initial aqueous mixture of about 5.6 LU
per gram of lactose in the aqueous mixture.
165. The use of claim 162 or 163, wherein the acid .beta.-D-galactoside galactohydrolase is for use at a concentration in the initial aqueous mixture of about 5.7 LU
per gram of lactose in the aqueous mixture.
166. The use of claim 162 or 163, wherein the acid .beta.-D-galactoside galactohydrolase is for use at a concentration in the initial aqueous mixture of about 5.8 LU
per gram of lactose in the aqueous mixture.
167. The use of any one of claims 162 to 166, wherein the neutral .beta.-D-galactoside galactohydrolase is for use at a concentration in the aqueous mixture of between 1 and 50 .beta.-D-galactoside galactohydrolase units (LU) per gram of lactose in the aqueous mixture.
168. The use of any one of claims 162 to 166, wherein the neutral .beta.-D-galactoside galactohydrolase is for use at a concentration in the aqueous mixture of about 4.4 LU
per gram of lactose in the aqueous mixture.
169. The use of any one of claims 162 to 166, wherein neutral .beta.-D-galactoside galactohydrolase is for use at a concentration in the aqueous mixture of about 4.5 LU
per gram of lactose in the aqueous mixture.
170. The use of any one of claims 162 to 166, wherein neutral .beta.-D-galactoside galactohydrolase is for use at a concentration in the aqueous mixture of about 4.6 LU
per gram of lactose in the aqueous mixture.
171. The use of any one of claims 162 to 166, wherein neutral .beta.-D-galactoside galactohydrolase is for use at a concentration in the aqueous mixture of about 4.7 LU
per gram of lactose in the aqueous mixture.
172. The use of any one of claims 162 to 171, wherein the acid .beta.-D-galactoside galactohydrolase is for incubation with the aqueous mixture prior to incubation of the aqueous mixture with the neutral .beta.-D-galactoside galactohydrolase.
173. The use of any one of claims 162 to 172, wherein the GOS syrup comprises at least about 60% GOS w/w of the total carbohydrate in the GOS syrup.
174. The use of any one of claims 162 to 172, wherein the GOS syrup comprises about 65% GOS w/w of the total carbohydrate in the GOS syrup.
CA2992497A 2016-01-12 2017-01-12 Method for producing galactooligosaccharides from lactose Active CA2992497C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662277838P 2016-01-12 2016-01-12
US62/277,838 2016-01-12
PCT/CA2017/050042 WO2017120678A1 (en) 2016-01-12 2017-01-12 Method for producing galactooligosaccharides from lactose

Publications (2)

Publication Number Publication Date
CA2992497A1 CA2992497A1 (en) 2017-07-20
CA2992497C true CA2992497C (en) 2020-12-22

Family

ID=59310498

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2992497A Active CA2992497C (en) 2016-01-12 2017-01-12 Method for producing galactooligosaccharides from lactose

Country Status (5)

Country Link
EP (1) EP3402892A4 (en)
CN (1) CN108138208A (en)
AU (1) AU2017207540A1 (en)
CA (1) CA2992497C (en)
WO (1) WO2017120678A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110914444A (en) * 2017-07-04 2020-03-24 株式会社益力多本社 Method for producing galactooligosaccharide
WO2023161321A1 (en) 2022-02-25 2023-08-31 Frieslandcampina Nederland B.V. Process for preparing high purity galacto-oligosaccharide
GB2616483A (en) * 2022-03-11 2023-09-13 Clasado Res Services Limited Oligosaccharide composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4095816B2 (en) * 2002-03-20 2008-06-04 日本オリゴ株式会社 Production method of galactooligosaccharide
EP2405918B2 (en) * 2009-03-13 2020-09-02 The Regents of The University of California Prebiotic oligosaccharides
WO2011093907A1 (en) * 2010-02-01 2011-08-04 Corn Products International, Inc. High-purity galactooligosaccharides and uses thereof
CN101831389B (en) * 2010-04-19 2011-12-07 江南大学 Strain for generating beta-D-galactosidase and method for producing galacto-oligosaccharides with same
CN102369998A (en) * 2010-08-13 2012-03-14 爱之味股份有限公司 Method for preparing easy-to-absorb low-lactose dairy product rich in galacto-oligosaccharide
TWI527522B (en) * 2010-08-13 2016-04-01 愛之味股份有限公司 Process for preparing milk product enhanced with galactooligosaccharide and easily absorbale, and functional milk product prepared therewith
EP2620506A1 (en) * 2012-01-25 2013-07-31 Arla Foods Amba Method of producing a galacto-oligosaccharide-containing composition
CN104812908A (en) * 2013-07-23 2015-07-29 新克莱玛有限公司 Method for producing galactooligosaccharide containing enhanced galactosyllactose as breast-milk ingredient
CN103993054B (en) * 2014-05-19 2016-05-25 山东龙力生物科技股份有限公司 A kind of enzyme coordinate system is for the method for high-purity oligomate
CN104805026A (en) * 2015-04-21 2015-07-29 山东福瑞达生物科技有限公司 Bacterial strain producing beta-galactosidase and method for preparing high-purity galactooligosaccharide
CN104975056B (en) 2015-07-21 2018-11-16 保龄宝生物股份有限公司 A kind of production method of high-content galactooligosaccharide
CN105274164A (en) * 2015-11-20 2016-01-27 保龄宝生物股份有限公司 Preparation method of galactooligosaccharides
CN105274165A (en) * 2015-11-20 2016-01-27 保龄宝生物股份有限公司 Simple production method of high-content galactooligosaccharides

Also Published As

Publication number Publication date
EP3402892A1 (en) 2018-11-21
WO2017120678A1 (en) 2017-07-20
EP3402892A4 (en) 2018-11-21
AU2017207540A1 (en) 2018-04-12
CA2992497A1 (en) 2017-07-20
CN108138208A (en) 2018-06-08

Similar Documents

Publication Publication Date Title
AU2008267279B2 (en) Novel prebiotics
EP2807264B1 (en) Method of producing a composition containing galacto-oligosaccharides
US20160369313A1 (en) Galacto-oligosaccharide-containing composition and a method of producing it
Silvério et al. Biocatalytic approaches using lactulose: end product compared with substrate
CA2992497C (en) Method for producing galactooligosaccharides from lactose
US10590448B2 (en) Production of galacto-oligosaccharides
US11718841B2 (en) Method for producing galactooligosaccharide
CA2991961C (en) Method for producing galactooligosaccharides from lactose
US10900058B2 (en) Method for producing galactooligosaccharides from lactose
JPH0522516B2 (en)
JPH02303450A (en) Preparation of cow's milk with reduced lactose content
US20220411455A1 (en) Method for producing galactooligosaccharides
KR20140081175A (en) Preparing method of isomalto oligosaccharide and isomalto oligosaccharide with reduced saccharide prepared by the same
JPH1118763A (en) Modification of beta-glactosidase
CN114568492A (en) Composition for producing brown milk drink, and method for producing same
JP2000041693A (en) Production of galactooligosaccharide
JPH02113867A (en) Preservation of sweetener
EP3362575A1 (en) Manufacture of polymeric sugars
JPH02299582A (en) Proliferation promoting agent and production thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180115